Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverTXMD
HealthcareNMSUSD

TherapeuticsMD, Inc.

$00123456789.00123456789001234567890.0%
52w low $0.99$2.95 52w high
Market data · last updated 1d ago
Market data
Market cap
$23.84M
52w range
$0.99 - $2.95
Beta
0.59
Sector
Healthcare
Data quality
92/100
Valuation
P/E ratio
206.0x
fair value estimate
$2.33
Margin of safety
+14.8%
Forward P/E
5.9x
Quality & efficiency
Moat score
45/100
Return on equity
0.3%
Profit margin
5.3%
Debt / equity
0.22
Growth & analysts
Revenue growth
+84.2%
Run the 10-point checklist before you buy How these numbers are made

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Valuation

ValueGrowthProfitHealthIncome55QUALITY
Overall Rating
52
Moderate quality
Moderate quality

Derived from filed metrics · High confidence (92% of the inputs available)

Moat Score45
Fair value estimate
$2.33+14.8% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$23.84M
P/E Ratio
206.0
Dividend Yield
0.00%
Revenue Growth
+84.2%
Profit Margin
5.3%
ROE
0.3%
Debt / Equity
0.22
Beta
0.59
High Growth

Statistics

Similar Stocks · Healthcare

Latest News · TXMD